Ignite Creation Date:
2025-12-25 @ 2:05 AM
Ignite Modification Date:
2026-05-11 @ 5:24 AM
Study NCT ID:
NCT01423760
Status:
TERMINATED
Last Update Posted:
2016-10-06
First Post:
2011-08-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Common Safety Follow-up Trial of Tecemotide (L-BLP25)
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EMR 63325-011
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None